Brandon Lawrence, MD (University of Utah) and Harvey E. Smith, MD (University of Pennsylvania Department of Orthopaedic Surgery) discuss cellular-based allografts.

Disclosures:

Lawrence, Brandon Douglas: Board of Directors: AO Spine North America (Nonfinancial, Paid directly to institution/employer),  Cervical Spine Research Society (Nonfinancial, Paid directly to institution/employer); Fellowship Support: AO Spine North America (E, Paid directly to institution/employer); Trips/Travel: AO Spine North America (B, Paid directly to institution/employer).

Smith, Harvey E.: Stock Ownership: Johnson And Johnson (200 Shares, 100.00%); Trips/Travel: Biedermann Medtech (A), Depuy/Johnson&Johnson (A), Nuvasive (Nonfinancial), Stryker (A).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+